Actionable news
0
All posts from Actionable news
Actionable news in CLVS: Clovis Oncology, Inc.,

Clovis Oncology Falls 8%: Here's What You Need To Know

Invest with Confidence. Are you a financial professional? Stay on top of your portfolio with Benzinga Pro's real-time newsfeed and alerts and never miss a headline again.
Don't miss the chance to try it FREE today.

Clovis Oncology, Inc. NASDAQ:CLVS - Clovis Oncology Falls 8%: Here's What You Need To Know

Shares of Clovis Oncology Inc CLVS 13.25% lost more than 8 percent on Friday after the company confirmed that the FDA posted briefing documents ahead of the Oncologic Drugs Advisory Committee (ODAC) meeting to discuss accelerated approval of the New Drug Application (NDA) for rociletinib.

The FDA recommended...


More